Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients.
A cyclosporine-ketoconazole drug interaction was first described in 1981. It has been suggested that the two drugs should not be used concomitantly because of the danger of severe nephrotoxicity. Two reported cases indicate that cyclosporine and ketoconazole can be safely coadministered, provided that the dosage of cyclosporine is reduced appropriately. Two patients were initially given 8 mg/kg/day of cyclosporine at the time of heart transplantation, and the dosage was tapered to meet appropriate blood levels (250 to 350 ng/ml by whole blood high-performance liquid chromatography). During ketoconazole therapy (400 mg daily for 4 weeks), patient 1 received 80 to 100 mg/day of cyclosporine, which is equal to approximately 1 mg/kg/day, and patient 2 received between 40 and 80 mg/day of cyclosporine, which is equivalent to 0.4 to 0.8 mg/kg/day. Neither patient exhibited a creatinine value above 1.4 mg/dl while on combined therapy, and there were no problems with allograft rejection. Both patients had inappropriately high cyclosporine blood levels even with this marked reduction in dosage (patient 1, 520 to 1310 ng/ml and patient 2, 320 to 600 ng/ml). Thus it appears that cyclosporine and ketoconazole can be administered together safely, provided that there is an appropriate reduction in the dosage of cyclosporine; this results in the maintenance of adequate immunosuppression without development of nephrotoxicity.
Schroeder
T J
TJ
Melvin
D B
DB
Clardy
C W
CW
Wadhwa
N K
NK
Myre
S A
SA
Reising
J M
JM
Wolf
R K
RK
Collins
J A
JA
Pesce
A J
AJ
First
M R
MR
D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D016027:Heart Transplantation; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects*; D008297:Male; D008875:Middle Aged
D003524:Cyclosporins; D007654:Ketoconazole